Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clarithromycin vs Metronidazole Triple Regimen in Pediatric H Pylori
NCT04721704Unknown
- Sponsor
- Shaheed Zulfiqar Ali Bhutto Medical University
- Start
- Sep 2020
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of clarithromycin and metronidazole in Helicobacter pylori gastritis (2 arms), sponsored by Shaheed Zulfiqar Ali Bhutto Medical University. Primary endpoint: Reduction in duration of symptoms and negative Stool H-Pylori-Ag at 2 weeks. Status: unknown.
02
Drugs
clarithromycinmetronidazole
03
Conditions
Helicobacter pylori gastritis
Beyond the preview
Go deeper on NCT04721704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04721704.